Construção e utilização de instrumento de estratificação de risco para vacinação de idosos contra a Covid-19 / Construction and use of a risk stratification instrument for vaccination of elderly against Covid-19 / Construcción y uso de un instrumento de estratificación de riesgo para la vacunación del anciano contra el Covid- 19

Objetivo: Relatar a experiência da construção e utilização de um instrumento de estratificação de risco para vacinação de idosos contra a COVID-19. Métodos: Relato da experiência desenvolvida no município de Massapê ­ Ceará, durante o ano de 2021, a partir do início da campanha de vacinação de idosos contra a COVID-19. Descrição da Experiência: Por conta da escassez de imunobiológicos, na fase inicial da vacinação contra a COVID-19, a Secretaria da Saúde do município de Massapê, estado do Ceará, criou um instrumento para estratificação de riscos sanitários, epidemiológicos e sociais dos idosos, contendo seus dados sociodemográficos e as comorbidades. Após o estabelecimento das variáveis, foram estabelecidos escores para os estratos de risco, que foram classificados em baixo (um a três pontos), médio (quatro a seis pontos), alto (sete a nove pontos) e muito alto (dez pontos e mais). Considerações Finais: O estudo mostra que, apesar da pandemia de COVID-19, uma crise sanitária global sem precedentes como já dito, ações pontuais, mesmo que localizadas, podem ter efeito em cadeia e ser replicadas em outros cenários e momentos.

Objective: To report the experience of building and using a risk stratification instrument for vaccinating the elderly against COVID-19. Methods: Report of the experience developed in the municipality of Massapê - Ceará, during the year 2021, from the beginning of the vaccination campaign for the elderly against COVID-19. Experience Description: Due to the scarcity of immunobiologicals, in the initial phase of vaccination against COVID-19, the Department of Health of the municipality of Massapê, state of Ceará, created an instrument to stratify the health, epidemiological and social risks of the elderly, containing sociodemographic data and comorbidities of the elderly. After establishing the variables, scores were established for the risk strata, which were classified as low (one to three points), medium (four to six points), high (seven to nine points) and very high (ten points and more). Final Considerations: The study shows that, despite the COVID-19 pandemic, an unprecedented global health crisis as already mentioned, specific actions, even if localized, can have a chain effect and be replicated in other scenarios and times.

Objetivo: Relatar la experiencia de construcción y uso de un instrumento de estratificación de riesgo para la vacunación de ancianos contra la COVID-19. Métodos: Informe de la experiencia desarrollada en el municipio de Massapê - Ceará, durante el año 2021, desde el inicio de la campaña de vacunación de ancianos contra la COVID-19. Descripción de la Experiencia: Debido a la escasez de inmunobiológicos, en la fase inicial de la vacunación contra la COVID-19, la Secretaría de Salud del municipio de Massapê, estado de Ceará, creó un instrumento para estratificar los riesgos sanitarios, epidemiológicos y sociales de los ancianos, que contiene datos sociodemográficos y comorbilidades de los ancianos. Luego de establecer las variables, se establecieron puntajes para los estratos de riesgo, los cuales se clasificaron en bajo (uno a tres puntos), medio (cuatro a seis puntos), alto (siete a nueve puntos) y muy alto (diez puntos y más). Consideraciones finales: El estudio muestra que, a pesar de la pandemia de COVID-19, una crisis sanitaria mundial sin precedentes como ya se mencionó, las acciones específicas, aunque sean localizadas, pueden tener un efecto en cadena y replicarse en otros escenarios y tiempos.

Capacitación para Campaña de Vacunación Encuentro 6

Campaña Nacional de Seguimiento

Esquema secuencial de vacunas neumocócicas. Módulo 12

Vía de administración. Indicaciones. Contraindicaciones. Efectos adversos. Registro de dosis aplicadas Carga nominal (CIPRES) Registro agrupado de dosis aplicadas oportunas y de recupero Carga en Inmunizaciones WEB

Vacunacion antirrábica en caninos y felinos de la Ciudad de Buenos Aires: Año 2021 / Rabies vaccination in Buenos Aires City: Year 2021

El objetivo del presente informe es exponer la situación actual de la vacunación antirrábica de la Ciudad de Buenos Aires, con el fin de realizar una planificación estratégica de prevención y control de la enfermedad. Se utilizaron datos sobre vacunación realizada por veterinarias privadas estimados a partir de la venta de talonarios por parte del Consejo Profesional de Médicos Veterinarios (CPMV); así como la vacunación realizada por los efectores públicos de salud: Instituto de Zoonosis Luis Pasteur (IZLP) y Mascotas de la Ciudad (MC).

Instituto Butantan entrega mais 1 milhão de doses da vacina

Saiba mais em www.vacinaja.sp.gov.br

Governo de SP inicia vacinação de agentes de segurança

Saiba mais em www.vacinaja.sp.gov.br

Começou a vacinação de profissionais ativos da segurança pública e administração penitenciária em SP

Saiba mais em www.vacinaja.sp.gov.br

Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.

BACKGROUND: Timely knowledge of which influenza vaccine brands are procured and where is of interest to inform site-selection for brand-specific influenza vaccine effectiveness (VE) studies. Vaccine procurement is a key determinant of brand availability. We therefore sought to understand how the procurement for seasonal influenza vaccine in Europe is organized, how this drives brand availability and how procurement data could enable to determine brand availability pre-season. METHODS: Structured telephone interviews were conducted with 15 experts in 16 European countries between 2017 and 2019 to collect information on the influenza vaccine procurement systems. Sources of (brand-specific) procurement data were identified and assessed on public accessibility. Vaccine type and brand availability and timelines were determined for the 2019-20 season to understand how procurement systems drive brand availability and diversity. RESULTS: Four main types of procurement systems for seasonal influenza vaccination campaigns were identified: national public tenders (Croatia, Denmark, Finland, Ireland, Lithuania, Netherlands, Norway, Scotland, Slovenia), regional public tenders (Italy, Spain, Sweden), direct purchase of vaccines by GPs (England, Wales) or pharmacies (Belgium, France, Germany, Greece) from manufacturers or wholesalers. National public tender outcomes are publicly available and timely; brand availability at clinic level can generally be deduced or narrowed down to two brands. Regional tender outcomes are more difficult to find, known very late or not available. In Italian and Spanish regions tenders may be awarded only a few weeks before the seasonal campaign. No public procurement information is available for countries with direct purchase. CONCLUSION: At the country-level, brand diversity is generally lower for countries with national public tenders than for countries with regional public tenders or direct purchase. In only a few countries, procurement data at the brand level is both publicly available and timely. Therefore the usefulness of procurement data for prospective site-selection for brand-specific VE studies is limited.

Sesión informativa sobre la COVID-19 en las Américas - 13/01/2021

Sesión informativa sobre la COVID-19 en las Américas. 13 de Enero, 2021 - original Español

Sesión informativa para prensa de la OPS sobre COVID-19 - 13/01/2021

Sesión informativa para prensa de la OPS sobre COVID-19 / PAHO’s virtual press briefing on COVID-19 - original audio

Press briefing PAHO COVID-19 - 01/13/2021

Press Briefing PAHO COVID-19 January 13 2021 - English audio

Sesión informativa sobre la COVID-19 en las Américas - 19/01/2021

Sesión informativa sobre la COVID-19 en las Américas. 13 de Enero, 2021 - audio Español

Sesión informativa para prensa de la OPS sobre COVID-19 - 19/01/2021

Sesión informativa para prensa de la OPS sobre COVID-19 / PAHO’s press briefing on COVID-19 - original audio

Press briefing PAHO COVID-19 - 01/19/2021

Press Briefing PAHO COVID-19 January 19 2021 - English audio

Sesión informativa COVID-19 en las Américas - 27/01/2021

Sesión informativa COVID-19 en las Américas. 27 de Enero, 2021 - audio Español

Sesión virtual informativa de la OPS sobre COVID-19 - 27/01/2021

Sesión virtual informativa de la OPS sobre COVID-19 / PAHO’s press briefing on COVID-19 -audio original

PAHO’s press briefing on COVID-19 - 01/27/2021

PAHO’s press briefing on COVID-19 - audio English

Conferencia de imprensa OPAS COVID 19 - 03/02/2021

Conferencia de Imprensa OPAS COVID 19 (3 de Fevereiro 2021) - Audio em Português

Conferencia de prensa de la OPS sobre COVID-19 - 03/02/2021

Conferencia de prensa de la OPS sobre COVID-19 / PAHO Press Briefing on COVID-19 - audio original